Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2021 | 4 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?
Int J Mol Sci. 2021 Dec 21;23(1):48. doi: 10.3390/ijms23010048.
Int J Mol Sci. 2021.
PMID: 35008473
Free PMC article.
Review.
Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer.
You KS, Yi YW, Cho J, Park JS, Seong YS.
You KS, et al.
Pharmaceuticals (Basel). 2021 Jun 18;14(6):589. doi: 10.3390/ph14060589.
Pharmaceuticals (Basel). 2021.
PMID: 34207383
Free PMC article.
Review.
Item in Clipboard
Anaplastic lymphoma kinase inhibitor NVP‑TAE684 suppresses the proliferation of human pancreatic adenocarcinoma cells.
Duong HQ, Than VT, Nguyen HT, Nguyen PT, Thi HTH, Bui TNH, Dang VPL, Dinh TT, You KS, Dang TH, Seong YS.
Duong HQ, et al. Among authors: you ks.
Oncol Rep. 2021 Apr;45(4):28. doi: 10.3892/or.2021.7979. Epub 2021 Mar 2.
Oncol Rep. 2021.
PMID: 33649854
Item in Clipboard
Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells.
Yi YW, You KS, Han S, Ha IJ, Park JS, Lee SG, Seong YS.
Yi YW, et al. Among authors: you ks.
Cancers (Basel). 2022 Oct 24;14(21):5215. doi: 10.3390/cancers14215215.
Cancers (Basel). 2022.
PMID: 36358633
Free PMC article.
Item in Clipboard
Inhibition of RPTOR overcomes resistance to EGFR inhibition in triple-negative breast cancer cells.
You KS, Yi YW, Kwak SJ, Seong YS.
You KS, et al.
Int J Oncol. 2018 Mar;52(3):828-840. doi: 10.3892/ijo.2018.4244. Epub 2018 Jan 15.
Int J Oncol. 2018.
PMID: 29344641
Item in Clipboard
Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in Triple-Negative Breast Cancer Cells.
You KS, Yi YW, Cho J, Seong YS.
You KS, et al.
Cancers (Basel). 2021 Mar 10;13(6):1205. doi: 10.3390/cancers13061205.
Cancers (Basel). 2021.
PMID: 33801977
Free PMC article.
Item in Clipboard
Silencing of NRF2 Reduces the Expression of ALDH1A1 and ALDH3A1 and Sensitizes to 5-FU in Pancreatic Cancer Cells.
Duong HQ, You KS, Oh S, Kwak SJ, Seong YS.
Duong HQ, et al. Among authors: you ks.
Antioxidants (Basel). 2017 Jul 1;6(3):52. doi: 10.3390/antiox6030052.
Antioxidants (Basel). 2017.
PMID: 28671577
Free PMC article.
Item in Clipboard
Cite
Cite